Ikhanda-Ikhanda - 1

umphumela

I-Ticagrelor Newgreen Supply APIS 99% Ticagrelor Powder

Incazelo emfushane:

Igama lomkhiqizo: Newgreen

Ukucaciswa Komkhiqizo: 99%

Impilo yeshelufu: 24month

Indlela yokugcina: Indawo epholile eyomile

Ukubukeka: I-White Powder

Isicelo: Imboni yezemithi

Ukupakisha: 25kg / isigubhu; I-1kg / foil bag noma izikhwama ezenziwe ngezifiso


Imininingwane Yomkhiqizo

Isevisi ye-OEM / ODM

Amathegi Omkhiqizo

Ukuchazwa Komkhiqizo

I-Ticagrelor iyimbangela ye-antipretlet, i-P2Y12 Receptor Antaing, esetshenziselwa ukuvikela izehlakalo zenhliziyo, ikakhulukazi ezigulini ezine-coronary syndrome (ACS). Yehlisa ubungozi be-thrombosis ngokuvimbela ukuhlanganiswa kwe-platelet.

Mechanics Main
Vimbela ukuhlanganiswa kwe-platelet:
I-Ticagrelor ibuyele emuva ku-P2Y12 receptor entweni yeplatelet, kuvimbela ukusebenza kwe-Platelet kanye nokuhlanganiswa okubangelwa yi-adenosine diphosphate (ADP), ngaleyo ndlela kunciphisa ukwakheka kwe-thrombus.

Izinkomba
I-Ticagrelor isetshenziswa ikakhulukazi kulezi zimo ezilandelayo:
I-Acute Coronary Syndrome:Kubandakanya iziguli ezine-angina ezingazinzile kanye ne-MyOCardial infarction, imvamisa esetshenziswa ngokuhlanganiswa ne-aspirin ukunciphisa ubungozi bezehlakalo zenhliziyo.
Ukuvimbela Kwesekondari Yezehlakalo Zezinhliziyo Zenhliziyo:Ezigulini ezivele zinomcimbi wenhliziyo ukuvimbela enye.

Coha

Into Ukucacisa Umphumela
Ukubonakala Umhlophe we-powder Qhubelelayo
Hlela -Yisimilo Qhubelelayo
Ngalokho ≥99.0% 99.8%
-Nembelelekile -Yisimilo Qhubelelayo
Ukulahleka kokuwomile 4-7 (%) 4.12%
Inani eliphelele I-8% max 4.85%
Insimbi esindayo ≤10 (PPM) Qhubelelayo
I-Arsenic (as) 0.5ppm max Qhubelelayo
Ukuhola (PB) 1ppm max Qhubelelayo
I-Mercury (HG) I-0.1ppm max Qhubelelayo
Isibalo sepuleti esiphelele I-10000cFu / g max. I-100cFU / g
I-Yeast & Mold I-100cFU / g max. >I-20cFU / g
Salmonella -Phikisayo Qhubelelayo
E.coli. -Phikisayo Qhubelelayo
Staphylococcus -Phikisayo Qhubelelayo
Ukugcina -Nokwazi
Ukubeka Gcina endaweni evaliwe kahle ngamazinga okushisa aphansi njalo futhi akukho ukukhanya kwelanga okuqondile.
Impilo yeshelufu Iminyaka emi-2 lapho igcinwa kahle

Umphumela wecala

I-Ticagrelor ngokuvamile ibekezelelwa kahle, kepha eminye imiphumela emibi kungenzeka, kufaka phakathi:

Isopha:Umphumela ojwayelekile ojwayelekile, ongaba nomphumela wezehlakalo ezithambile noma ezinzima zokopha.

Ubunzima bokuphefumula:Ezinye iziguli zingathola ubunzima bokuphefumula noma ukukhwehlela.

Ukusabela kwesisu:njenge-nausea, ubuhlungu besisu noma ukugayeka.

Amanothi

Ingozi yokuphamba:Ingozi yokopha kufanele ibhekwe njalo lapho usebenzisa iTicagrelor, ikakhulukazi lapho isetshenziswa ngokuhlangenwe nakho nezinye izidakamizwa eziphikisayo.

Umsebenzi we-Hepatic:Sebenzisa ngokuqapha ezigulini ezinokukhubazeka kwe-hepatic; Ukulungiswa kwethamo kungadingeka.

Ukusebenzisana kwezidakamizwa:I-Ticagrelor ingaxhumana nezinye izidakamizwa. Kufanele utshele udokotela wakho ngazo zonke izidakamizwa ozithathayo ngaphambi kokuyisebenzisa.

Iphakheji nokulethwa

1
2
+

  • Okwedlule:
  • Olandelayo:

  • Oemodmrvice (1)

    Bhala umyalezo wakho lapha bese usithumela kithi